About Braden’s Hope

Braden’s Hope For Childhood Cancer is named after Braden Hofen who was diagnosed with Stage IV Neuroblastoma when he was three years old. He was given a 30% chance of survival and went through a year and a half of treatment. Three months after finishing treatment, Braden’s Neuroblastoma relapsed and there is no known cure for relapsed Neuroblastoma. Braden’s odds fell to less than 10%.

Two months after his relapse, his mom, Deliece, was diagnosed with Stage II breast cancer and had numerous targeted treatments available to her. They fought cancer at the same time and had chemotherapy on the same days in two different locations in Kansas City.

During her treatment, Deliece began researching to find out why there was such a discrepancy between what was available for her compared to her son and she learned that childhood cancers are grossly over-looked and under-funded in comparison to adult cancers. The Hofens and their friends started Braden’s Hope For Childhood Cancer to try to insure no other family would hear the words, “No Known Cure”.

Braden achieved a second remission and Deliece achieved a remission as well. In 2013, Braden would be diagnosed with a secondary form of leukemia that was caused by the treatments he had to save his life from Neuroblastoma. The doctors told the Hofens that they had never seen a child survive this form of leukemia after relapsed neuroblastoma. The only cure was a bone marrow transplant and Braden found a perfect match in his then ten year old brother, Zach.

Braden is defying odds and remains in a remission from both of his cancers. Braden, his family, their friends, and the entire Kansas City community continues to work to find targeted treatments of childhood cancers to shut the activators down so children can live long, healthy lives after cancer diagnoses.



Our Research Review Board works collaboratively with researchers and leaders at Children’s Mercy Hospital and KU Cancer Center, both in Kansas City, to create research studies that meet the mission of Braden’s Hope For Childhood Cancer. Our Research Review Board then insures that the work of the research study is being conducted appropriately, dollars are being spent according the the submitted budget, and results of the studies are helping children have hope for a future through our rigorous reporting procedures and requirements. Children’s Mercy Hospital has just announced plans to open a new research center that will offer one of the most innovative centers in the country to do house the research we are funding.


Dave Flickinger, President of Kiewit Power in Kansas City, describes why their company and employees choose to fund through Braden’s Hope For Childhood Cancer. Watch this 90 second video and you will see the advantage to both our sponsors and our Hope Heroes.

Braden’s Hope – Kiewit from David Moore on Vimeo.